path_2603_sm_suppinfof1.tif3339KSupporting Information: Supplementary Figure S1. Long-term in vitro passaged cells and tumour cells acquire genetic aberrations; an overview of genomic aberrations observed in all cell lines used
path_2603_sm_suppinfot1.doc21KSupporting Information: Supplementary Table S1. Summary of all conditions under which the named antibodies perform optimally, also showing the companies' names
path_2603_sm_suppinfofigcap.doc20KSupporting Information: Legends Figure S1
path_2603_sm_suppinfosummary.doc23KSupporting Information: Summary of the clinical and follow-up data of all patients used in the study

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.